Answers are grounded in this paper and cite their sources.
Kallmann syndrome is a rare, genetically determined combination of gonadotropin-releasing hormone deficiency and hypo- and anosmia. It is reported to occur in 1:10.000 men and 1:50.000 women. The main genes in which mutations in KS are found are KAL1, NSMF, WDR11, GNRHR, and others. In addition to disorders of sexual development and olfaction, KS can manifest as agenesis of the kidneys, teeth, polydactyly, scoliosis, and lesions of the nervous system. Treatment of KS in women includes the use of estrogen-progestin therapy to induce and maintain the development of secondary sexual characteristics and gonadotropin therapy to ensure fertility. In this paper we describe a case of diagnostics and treatment of a 20-year-old female patient, who had been trying to find the cause of her condition for a long time without success before coming to our clinic.
No takes yet. Share an insight, caveat, or question.
Rumyantseva et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: